GUFIC BIOSCIENCES Financial Statement Analysis
|
||
|
The Revenues of GUFIC BIOSCIENCES have increased by 0% YoY .
The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has increased by 0 YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
GUFIC BIOSCIENCES Last 5 Annual Financial Results
[BOM: 509079|NSE : GUFICBIO]
| Consolidated | Mar2024 |
|---|---|
| Revenues | ₹0.00 Cr |
| Expenses | ₹0.00 Cr |
| Operating Profit (Excl OI) | ₹0.00 Cr |
| Other Income | ₹0.00 Cr |
| Interest | ₹0.00 Cr |
| Depreciation | ₹0.00 Cr |
| Profit Before Tax | ₹0.00 Cr |
| Profit After Tax | ₹0.00 Cr |
| Consolidated Net Profit | ₹0.00 Cr |
| Earnings Per Share (Rs) | ₹8.59 |
| PAT Margin (%) | 9.16 |
| ROE(%) | 16.17 |
| ROCE(%) | 15.42 |
| Total Debt/Equity(x) | 0.60 |
Key Financials |
||
| Market Cap | : | ₹ 3,507.5 Cr |
| Revenue (TTM) | : | ₹ 819.8 Cr |
| Net Profit(TTM) | : | ₹ 69.7 Cr |
| EPS (TTM) | : | ₹ 6.9 |
| P/E (TTM) | : | 50.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GUFIC BIOSCIENCES | 0.3% | -5.6% | -1.5% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.6% | 0.8% | 10.5% |
| DIVIS LABORATORIES | 3.1% | 3.8% | 49.2% |
| CIPLA | 0.4% | 2.5% | 1.2% |
| TORRENT PHARMACEUTICALS | -0.2% | 6.4% | 20.5% |
| DR REDDYS LABORATORIES | -0.6% | 3.3% | 0.1% |
| MANKIND PHARMA | 1.3% | 0.7% | 10.4% |
| ZYDUS LIFESCIENCES | 1.8% | 7.3% | -6.7% |
| LUPIN | 1% | 0.7% | 21.7% |
GUFIC BIOSCIENCES Revenues
[BOM: 509079|NSE : GUFICBIO]
| Y-o-Y | 0 % |
| 5 Yr CAGR | 0 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹0.00 Cr | - | |
GUFIC BIOSCIENCES Operating Profit
[BOM: 509079|NSE : GUFICBIO]
| Y-o-Y | 0 |
| 5 Yr CAGR | 0 |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹0.00 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 0 |
| 5 Yr CAGR | 0 |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 0% | - | |
GUFIC BIOSCIENCES Profit After Tax
[BOM: 509079|NSE : GUFICBIO]
| Y-o-Y | 0 |
| 5 Yr CAGR | 0 |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹0.00 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 0 |
| 5 Yr CAGR | 0 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 9.16 % | - | |
GUFIC BIOSCIENCES Earnings Per Share (EPS)
[BOM: 509079|NSE : GUFICBIO]
| Y-o-Y | 0 |
| 5 Yr CAGR | 0 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹8.59 | - | |
GUFIC BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 509079|NSE : GUFICBIO]
| Y-o-Y | 0 |
| 5 Yr CAGR | 0 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 15.42% | - | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Current Share Price | : | ₹349.7 |
| Current MarketCap | : | ₹ 3,507.5 Cr |
| Updated EOD on | : | Jul 03,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | 0.3% |
-5.6% |
-1.5% |
| SENSEX | -0.6% |
3.1% |
5.3% |
GUFIC BIOSCIENCES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE HEALTHCARE | 2% | 4.8% | 20.2% |
| BSE SMALLCAP | 1.4% | 4.1% | 5% |
No NSE index found
You may also like the below Video Courses
FAQ about GUFIC BIOSCIENCES Financials
How the annual revenues of GUFIC BIOSCIENCES have changed ?
The Revenues of GUFIC BIOSCIENCES have increased by 0% YoY .
How the Earnings per Share (EPS) of GUFIC BIOSCIENCES have changed?
The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has increased by 0 YoY .
Check out Intrinsic Value of Peers of GUFIC BIOSCIENCES
Compare Stock Analytics of Peers of GUFIC BIOSCIENCES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
